Name | Value |
---|---|
Revenues | 263.2M |
Cost of Revenue | 184.4M |
Gross Profit | 78.9M |
Operating Expense | 58.7M |
Operating I/L | 20.2M |
Other Income/Expense | -7.0M |
Interest Income | 1.1M |
Pretax | 12.9M |
Income Tax Expense | 4.5M |
Net Income/Loss | 8.4M |
Phibro Animal Health Corporation develops, manufactures, and supplies animal health and mineral nutrition products for livestock in the United States and internationally. The company's products include antibacterials, anticoccidials, anthelmintics, anti-bloat treatments, nutritional specialty products, vaccines, trace minerals, and specialty ingredients. These products are sold to integrated poultry, swine, and cattle integrators, as well as commercial animal feed manufacturers, wholesalers, and distributors. Phibro operates through three segments: Animal Health, Mineral Nutrition, and Performance Products, generating revenue by providing a range of health and nutrition solutions for food animals, including poultry, swine, beef and dairy cattle, and aquaculture.